BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2008
View Archived Issues
Shionogi-GlaxoSmithKline starts phase IIa study with GSK-1349572 in HIV patients
Read More
GSK's 5-HT6 receptor antagonist SB-742457 improves global function in mild-to-moderate AD
Read More
Tau aggregation inhibitor rember stops Alzheimer's disease progression
Read More
Novel potent O-GlcNAcase inhibitor blocks Tau phosphorylation in preclinical studies
Read More
Novel CDK-2 receptor inhibitor shows preliminary antitumor effects in mice
Read More
Recent patents describe novel therapeutic agents for asthma and other respiratory disorders
Read More
Novel anticancer agents disclosed in recent patent literature
Read More
Preliminary data shows phase III Cerepro trial meets primary endpoint
Read More
IDEA presents an update on the clinical development of Diractin for knee OA
Read More
Synairgen initiates enrollment in SG004 phase I clinical study of IFN-beta for asthma
Read More
Celator series C private financing to advance clinical development programs
Read More
Clavis Pharma amends clinical program for Elacyt
Read More
FDA accepts labeling regarding food in IntelGenx's and Cary's NDA for CPI-300
Read More
ImQuest receives SBIR grant from the NIAID to develop pyrimidinedione product in HIV
Read More
Cytochroma and Mitsubishi Tanabe sign a U.S. and Asian license agreement for CTA-018
Read More
AtheroGenics reports positive results from phase III ANDES trial in diabetes
Read More
Roche files European MAA for MabThera for chronic lymphocytic leukemia
Read More
Medicago presents a report on activities during the first 7 months of 2008
Read More
Orexo and ProStrakan extend licensing agreement for Rapinyl to include North America
Read More
New agents intended for use in treatment of anxiety, depression, etc., disclosed in recent patents
Read More
Sanofi pasteur begins shipping Fluzone influenza vaccine for the 2008-2009 season
Read More
PolyMedix completes USD 15 million registered equity financing
Read More
Genmab and GSK report positive results from phase III study of ofatumumab in CLL
Read More
Biota reports positive results from phase II clinical study of CS-8958 in influenza
Read More
FDA confirms that no additional trials required in Cadence's NDA for Acetavance
Read More